Arkolith/Insider Trading/CORT/Form 4

Belanoff Joseph K

Chief Executive Officer, DirectorCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$895K
Net Open-Market Flow
-$895K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Sell(S)13K$69.74$895K2.6M
May 29, 2026Gift(G)300K—$02.6M
May 29, 2026Gift(G)150K—$0150K
May 29, 2026Gift(G)150K—$0150K

Transaction Codes

S
Open-market sale
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-253459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML